
Wolf Popper LLP Announces Investigation on Behalf of Tempus AI, Inc. Investors
/EIN News/ -- NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Wolf Popper LLP is investigating potential claims on behalf of purchasers of Tempus AI, Inc. (“Tempus”) common stock (NASDAQ: TEM).
Tempus uses AI to provide medical solutions to physicians.
Before the market opened on May 28, 2025, Spruce Point Capital Management published a report entitled The Tempest Surrounding Tempus AI. The report discussed 1) Tempus’ CEO and a large Tempus shareholder have been associated with several companies that have either gone bankrupt or have done very poorly as public companies, 2) several Tempus board members and Tempus’ Chief Accounting Officer have been connected to companies that had to restate their financials, 3) potential financial irregularities and related party issues, 4) whether Tempus’ technology actually works, and 5) the selling of Tempus shares by insiders.
On this news, Tempus’ stock price fell $12.67 per share to $53.20 on May 28, 2025, down 19.2% on very heavy volume.
Investors who lost over $50,000 trading in Tempus common stock and who would like to discuss the investigation should contact Adam Savett at (212) 451-9655, or asavett@wolfpopper.com.
Wolf Popper has successfully recovered billions of dollars for defrauded investors. Wolf Popper’s reputation and expertise have been repeatedly recognized by courts that have appointed the firm to major positions in securities litigation. For more information about Wolf Popper, please visit the Firm’s website at www.wolfpopper.com.
May Be Considered Attorney Advertising in Certain Jurisdictions.
Prior Results Do Not Guarantee a Similar Outcome.
Wolf Popper LLP
Adam Savett
845 Third Avenue
New York, NY 10022
Tel.: (212) 451-9655
Email: asavett@wolfpopper.com


Distribution channels: Consumer Goods, Law ...
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release